An alternative nonclinical approach to support the first-in-human clinical trial of a T-cell bispecific targeting EGFRvIIIElisabeth Husar, Antje‐Christine Walz, Angélique Augustin et al.|Journal of Pharmaceutical Sciences|2025Cited by 0